Re: “Prediction of skeletal-related events in patients with non-small cell lung cancer”—use of Spine Instability Neoplastic Score (SINS)

被引:0
|
作者
Estanislao Arana
Francisco M. Kovacs
Ana Royuela
Beatriz Asenjo
Úrsula Pérez-Ramírez
Javier Zamora
机构
[1] Valencian Oncology Institute Foundation,Department of Radiology
[2] Research Institute in Health Services Foundation,Spanish Back Pain Research Network
[3] Kovacs Foundation,Spanish Back Pain Research Network
[4] Unidad de la Espalda Kovacs,UGC de Radiología
[5] Hospital Universitario Moncloa,Center for Biomaterials and Tissue Engineering
[6] CIBER Epidemiology and Public Health (CIBERESP),Barts and the London School of Medicine & Dentistry
[7] Complejo Hospitalaria Universitario de Granada,undefined
[8] Universitat Politècnica de València,undefined
[9] Clinical Biostatistics Unit Hospital Ramón y Cajal,undefined
[10] IRYCIS,undefined
[11] Queen Mary University of London,undefined
来源
Supportive Care in Cancer | 2016年 / 24卷
关键词
Bone Metastasis; Assessment Tool; Radiation Oncologist; Medical Oncologist; Routine Clinical Practice;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3273 / 3274
页数:1
相关论文
共 50 条
  • [31] A fourteen-lncRNA risk score system for prognostic prediction of patients with non-small cell lung cancer
    Song, Jia-Yi
    Li, Xiao-Ping
    Qin, Xiu-Jiao
    Zhang, Jing-Dong
    Zhao, Jian-Yu
    Wang, Rui
    CANCER BIOMARKERS, 2020, 29 (04) : 493 - 508
  • [32] Non-small Cell Lung Cancer as Skeletal Muscle Metastasis
    Rahul Peravali
    Ali Azim
    Khawaja Muddassir
    Journal of General Internal Medicine, 2021, 36 : 3573 - 3574
  • [33] Non-small Cell Lung Cancer as Skeletal Muscle Metastasis
    Peravali, Rahul
    Azim, Ali
    Muddassir, Khawaja
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (11) : 3573 - 3574
  • [34] Bone modifying agents and skeletal related events in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors.
    Das, Parthib
    Zhao, Songzhu
    Wei, Lai
    Miah, Abdul
    Li, Mingjia
    Lopez, Gabrielle
    Patel, Sandip H.
    Johns, Andrew
    Grogan, Madison
    Bertino, Erin Marie
    He, Kai
    Shields, Peter G.
    Carbone, David Paul
    Otterson, Gregory Alan
    Presley, Carolyn J.
    Owen, Dwight Hall
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] ASSESSING THE UTILIZATION OF DIABETIC NON-SMALL CELL LUNG CANCER PATIENTS COMPARED TO NON-SMALL CELL LUNG CANCER PATIENTS
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W.
    VALUE IN HEALTH, 2017, 20 (09) : A511 - A511
  • [36] Thromboembolic events in advanced non-small cell lung cancer
    Srinivasalu, V. K.
    Subramaniam, N.
    Raghuram, S.
    Kolathu, S.
    Ponnada, B.
    Philip, A.
    Jose, W. M.
    Pavithran, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Comparison of the incidence of skeletal related events (SREs) between non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)
    Morise, M.
    Kondo, M.
    Hasegawa, Y.
    ANNALS OF ONCOLOGY, 2015, 26 : 119 - 119
  • [38] RISK FACTORS FOR SKELETAL-RELATED EVENT (SRES) IN ZOLEDRONIC ACID-TREATED PATIENTS WITH BONE METASTASES (METS) FROM NON-SMALL CELL LUNG CANCER (NSCLC)
    Brown, J.
    Cook, R.
    Hirsh, V.
    Major, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 275 - 275
  • [39] The use of docetaxel in non-small cell lung cancer
    Bishop, JF
    Clarke, SJ
    UPDATES IN ADVANCES IN LUNG CANCER, 1997, 29 : 106 - 116
  • [40] Skeletal-related events and overall survival of patients with bone metastasis from nonsmall cell lung cancer - A retrospective analysis
    Kong, Pengyu
    Yan, Jinglong
    Liu, Donghui
    Ji, Ye
    Wang, Yufu
    Zhuang, Jinpeng
    Wang, Jincai
    Hu, Xiaowei
    Yue, Xiaolong
    MEDICINE, 2017, 96 (51)